William Patrick Slattery

Contributor   in
AI and Big Data  

William Patrick Slattery is the President, and CEO of Nieuw Amsterdam Advisors, a life sciences consulting firm. He is regarded as one of the top marketing experts in the Life Sciences industry noted for combining a calm demeanor with a shrewd negotiation skill set that allows for navigating the most challenging business environments on behalf of his client firms.

tags:   Artificial Intelligence     AI in Drug Discovery    

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Posts by this author

The Many Ways Pharma Industry Is Benefitting from Artificial Intelligence

   428
The Many Ways Pharma Industry Is Benefitting from Artificial Intelligence

Artificial Intelligence (A.I.) has revolutionized many industries as we speak, which doesn't exclude pharmaceuticals. However, unlike other sectors concerning Information Technology, Automotive, Entertainment, and the likes, pharma was reasonably slow in adopting the futuristic technology but getting there nonetheless. The slow acceptance and incorporation of A.I. within pharma owes to the blatant uncertainty of what might work and what won't help discover and develop new drugs.